This study aimed to examine the expression and potential prognostic value of Survivin, as well as P53, BCL-2 and markers of the cellular process of apoptosis and proliferation, in pancreatic and ampullary cancers. The gene discussed is BIRC5; the disease is carcinoma of the ampulla of vater.